GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $28,943,000 | -0.1% | 664,890 | +0.0% | 0.68% | +17.3% |
| Q1 2022 | $28,959,000 | +16.8% | 664,800 | +20.1% | 0.58% | +31.5% |
| Q4 2021 | $24,784,000 | +43.9% | 553,600 | +22.8% | 0.44% | +28.3% |
| Q3 2021 | $17,220,000 | -0.3% | 450,680 | +3.9% | 0.35% | -2.3% |
| Q2 2021 | $17,269,000 | +11.6% | 433,687 | 0.0% | 0.35% | +2.6% |
| Q1 2021 | $15,478,000 | -3.4% | 433,687 | -0.4% | 0.34% | -4.7% |
| Q4 2020 | $16,025,000 | -3.3% | 435,457 | -1.1% | 0.36% | -14.2% |
| Q3 2020 | $16,571,000 | -7.6% | 440,257 | +0.1% | 0.42% | -16.3% |
| Q2 2020 | $17,940,000 | +8.7% | 439,807 | +1.2% | 0.50% | -5.6% |
| Q1 2020 | $16,503,000 | -16.6% | 434,407 | +3.2% | 0.53% | -0.2% |
| Q4 2019 | $19,778,000 | +10.3% | 420,902 | +0.2% | 0.54% | +2.7% |
| Q3 2019 | $17,934,000 | +6.6% | 420,202 | 0.0% | 0.52% | +5.5% |
| Q2 2019 | $16,816,000 | -4.2% | 420,202 | 0.0% | 0.49% | -3.5% |
| Q1 2019 | $17,560,000 | +14.5% | 420,202 | +4.7% | 0.51% | -0.8% |
| Q4 2018 | $15,331,000 | -3.9% | 401,237 | +1.0% | 0.52% | +11.0% |
| Q3 2018 | $15,952,000 | +11.6% | 397,107 | +12.0% | 0.46% | +1.5% |
| Q2 2018 | $14,290,000 | +3.2% | 354,507 | 0.0% | 0.46% | +4.1% |
| Q1 2018 | $13,851,000 | +10.2% | 354,507 | 0.0% | 0.44% | +14.3% |
| Q4 2017 | $12,574,000 | -12.6% | 354,507 | 0.0% | 0.38% | -17.4% |
| Q3 2017 | $14,393,000 | -19.0% | 354,507 | -14.0% | 0.47% | -21.0% |
| Q2 2017 | $17,778,000 | +2.2% | 412,300 | -0.1% | 0.59% | -0.2% |
| Q1 2017 | $17,399,000 | +9.5% | 412,700 | 0.0% | 0.59% | +5.9% |
| Q4 2016 | $15,893,000 | -10.9% | 412,700 | -0.2% | 0.56% | -4.1% |
| Q3 2016 | $17,832,000 | -0.7% | 413,450 | -0.2% | 0.58% | +1.2% |
| Q2 2016 | $17,962,000 | +0.2% | 414,450 | -0.1% | 0.58% | +0.2% |
| Q1 2016 | $17,920,000 | +7.1% | 414,850 | 0.0% | 0.57% | +11.0% |
| Q4 2015 | $16,739,000 | +4.9% | 414,850 | 0.0% | 0.52% | +3.2% |
| Q3 2015 | $15,951,000 | -25.6% | 414,850 | -19.4% | 0.50% | -16.8% |
| Q2 2015 | $21,444,000 | -32.2% | 514,850 | -22.5% | 0.60% | -29.0% |
| Q1 2015 | $31,609,000 | +11.3% | 664,550 | 0.0% | 0.85% | +14.3% |
| Q4 2014 | $28,403,000 | -7.0% | 664,550 | 0.0% | 0.74% | -9.3% |
| Q3 2014 | $30,549,000 | -14.1% | 664,550 | -0.1% | 0.82% | -11.6% |
| Q2 2014 | $35,562,000 | +0.1% | 664,950 | 0.0% | 0.92% | -1.0% |
| Q1 2014 | $35,528,000 | +0.1% | 664,950 | 0.0% | 0.93% | +3.1% |
| Q4 2013 | $35,502,000 | +6.7% | 664,950 | +0.2% | 0.91% | +2.5% |
| Q3 2013 | $33,285,000 | -0.3% | 663,450 | -0.7% | 0.88% | -3.1% |
| Q2 2013 | $33,377,000 | – | 667,950 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |